Clinical Trial Update: Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma [Phase 2]

View source ↗

Summary

Phase II study in children with high-risk melanoma evaluating pegylated interferon as part of treatment. Results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Pegylated Interferon Alfa-2b (pegylated interferon alfa-2b)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Malignant Melanoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2014-02-27